Sacroiliitis Treatment Market to Reach USD 3.42 Billion by 2034

Pune, India, November 2025 - According to a new report by Exactitude Consultancy, the Global Sacroiliitis Treatment Market is valued at USD 2.1 billion in 2024 and is projected to reach USD 3.42 billion by 2034, growing at a CAGR of 5.0% from 2025 to 2034. The increasing prevalence of chronic lower back pain, osteoarthritis, and inflammatory joint diseases-combined with innovations in targeted biologics and minimally invasive procedures-are fueling the growth of this market.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49158

Key Takeaways
• Market Value (2024): USD 2.1 Billion
• Forecast (2034): USD 3.42 Billion
• CAGR (2025-2034): 5.0%
• Primary Growth Drivers: Advancements in biologics, image-guided injections, and improved diagnosis of sacroiliac joint dysfunction.
• Top Players: Pfizer Inc., AbbVie Inc., Johnson & Johnson, Novartis AG, Eli Lilly and Company, Stryker Corporation, Zimmer Biomet, and Medtronic plc.

Market Story
Sacroiliitis-an inflammation of the sacroiliac joints linking the lower spine to the pelvis-represents one of the leading causes of chronic lower back pain, affecting millions globally. The condition is often associated with ankylosing spondylitis, osteoarthritis, trauma, and pregnancy-related stress.
The growing clinical focus on early diagnosis and targeted therapy has transformed the treatment landscape. Traditional management with NSAIDs and corticosteroid injections is now being complemented by biologic drugs, radiofrequency ablation, and minimally invasive sacroiliac joint fusion procedures.

Imaging advancements-including MRI, ultrasound, and CT-guided injections-are improving diagnostic accuracy and precision in targeted therapy delivery. Furthermore, the growing prevalence of sedentary lifestyles and aging populations is expanding the patient pool for sacroiliitis treatment.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49158/sacroiliitis-treatment-market

Market Segmentation
By Treatment Type:
• Medications (NSAIDs, Corticosteroids, Biologics, Analgesics)
• Injections (Steroid & Platelet-Rich Plasma)
• Surgical Procedures (Joint Fusion, Minimally Invasive Techniques)
• Physical Therapy & Rehabilitation

By Route of Administration:
• Oral
• Parenteral
• Others

By End-User:
• Hospitals
• Orthopedic Clinics
• Rehabilitation Centers
• Ambulatory Surgical Centers

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: AbbVie Inc. reported positive outcomes for its IL-17 inhibitor therapy in treating sacroiliac joint inflammation in ankylosing spondylitis patients.
• 2024: Stryker Corporation introduced a next-generation sacroiliac fusion implant for minimally invasive orthopedic surgeries.
• 2024: Pfizer collaborated with clinical centers to evaluate biologic therapies for chronic sacroiliitis linked to autoimmune disorders.
• 2023: Zimmer Biomet expanded its spine and joint repair portfolio with novel devices for sacroiliac joint stabilization.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49158

Expert Insight
"The sacroiliitis treatment market is entering a transformative phase, led by biologics and precision-guided interventions," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"As diagnostic imaging and therapeutic delivery become more advanced, clinicians can now manage sacroiliitis more effectively-reducing pain, restoring mobility, and improving patient quality of life."

Regional Outlook
• North America dominates with over 40% share, driven by advanced orthopedic infrastructure and high awareness of musculoskeletal disorders.
• Europe benefits from increased biologic adoption and national spine-care programs.
• Asia Pacific is the fastest-growing region (CAGR above 6.5%), supported by growing healthcare expenditure, aging populations, and expanded diagnostic capabilities in India, Japan, and China.
• Latin America & Middle East are emerging markets focused on improving orthopedic surgical accessibility and chronic pain management solutions.

Conclusion
The Sacroiliitis Treatment Market is evolving with innovations in imaging, biologics, and minimally invasive surgeries that enhance diagnostic precision and therapeutic success. As global awareness of chronic back pain and joint dysfunction increases, integrated care approaches will shape the next decade of growth in this market.

This report is also available in the following languages : Japanese (仙腸関節炎の治療), Korean (천골장골염 치료), Chinese (骶髂关节炎治疗), French (Traitement de la sacro-iliite), German (Behandlung der Sakroiliitis), and Italian (Trattamento della sacroileite), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49158

Our More Reports:

Integrated Operating Room Management Systems Market
https://exactitudeconsultancy.com/reports/49163/integrated-operating-room-management-systems-market

Corporate Wellness Market
https://exactitudeconsultancy.com/reports/49166/corporate-wellness-market

Biochips Market
https://exactitudeconsultancy.com/reports/49169/biochips-market

Oncology Information Systems Market
https://exactitudeconsultancy.com/reports/49172/oncology-information-systems-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.